Navigation Links
Acne Treatment Brand, Probiotic Action, Comments on the Use of a Virus to Treat Acne
Date:2/27/2013

(PRWEB) February 27, 2013

On Feb 27, 2013, acne treatment company, Probiotic Action, comments on UCLA and University of Pittsburgh’s suggestion of a natural virus living on our skin being used to treat acne breakouts.

According to Medical News Today, scientists at the University of California, Los Angeles and the University of Pittsburgh are attempting to use a naturally-occurring virus that feeds on Propionibacterium acnes, a bacterium growing in human pores that cause acne outbreaks. They intend to extract these viruses in the hopes of creating new methods for combating this affliction.

The need for a new way to combat acne has come, partially, due to traditional preventative measures no longer working as effectively. Dr. Jenny Kim, Director of UCLA’s Clinic for Acne, Rosacea, and Aesthetics, comments on this in Medical News Today. She discusses how various strains of acne will build up immunities to conventional methods of preventative treatments, such as the antibiotic, tetracycline. She also went into detail on the potentially scarring consequences of acne outbreaks and how imperative it is to find alternative forms of treatment.

Adult acne treatment company, Probiotic Action, comments on this new research venture. According to Fernando Perez, a representative of Probiotic Action, “Regardless of the field, looking to new research materials and experimenting is the only way to improve, and that is no different in regards to acne prevention.” He continued, “Utilizing naturally-occurring viruses instead of potentially harmful chemicals shows a concern for those that suffer from acne breakouts. We hope for success from this line of research and hope it opens up new methods for combating acne breakouts.”

Probiotic Action is an advanced acne treatment that uses a topical probiotic containing the “good bacteria” that is naturally found on healthy human skin. By using probiotics, Probiotic Action is an effective treatment that restores the normal bacteria content on skin. Probiotic Action will successfully clear skin while protecting skin against bad bacteria, free radicals, and pollutants.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10466077.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Researchers shrink tumors and minimize side effects using tumor-homing peptide to deliver treatment
2. Roche Signs Agreement with PTC Therapeutics to Advance Treatment for Spinal Muscular Atrophy (SMA)
3. Nutra Pharma Announces Publication of a New Mechanism Study of Alpha-Cobratoxin in the Treatment of Pain
4. Emerging Lymphoma and Myeloma Treatments Focus on Improving Individual Patient Response
5. Intravenous Remodulin Approved for the Treatment of Pulmonary Arterial Hypertension in Most of the European Union
6. Baxter Initiates Phase I Clinical Trial of Longer-acting Recombinant FVIII Treatment for Hemophilia A
7. SFJ Pharma Ltd. II, Announces Agreement With Pfizer to Develop Axitinib for Adjuvant Treatment of Renal Cell Carcinoma
8. MarketsandMarkets: Global Seed Treatment Market worth $3430.3 Million by 2016
9. LoneStar Heart Acquires Worldwide Exclusive Rights to New Class of Small Molecules That May Lead to New Treatments for Diabetes
10. Ultragenyx Granted Orphan Drug Designation for UX003 for the Treatment of Mucopolysaccharidosis Type 7 (MPS 7)
11. Biotech Firm Spun Off from Childrens Hospital Raises $7 Million to Advance Magnetic-Based Vascular Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):